A collection of content all about sofosbuvir.

Oct 28, 2019: The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.

Dec 3, 2018: A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco

Dec 5, 2018: A recent study of people in British Columbia found, however, that people who inject drugs had lower cure rates.

Apr 19, 2019: Triumeq is a single-tablet regimen HIV medication. Triumeq was approved by the FDA in August 2014.

Jul 22, 2019: Pharmacists oversaw the delivery of hepatitis C treatment in a recent study.

Oct 15, 2019: The drug can quickly reverse opioid-driven overdoses.

Jul 27, 2019: Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.

Apr 24, 2018: In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.

Jul 5, 2018: In a recent study, even the presence of viral mutations associated with resistance to treatment did not affect the cure rate.

Feb 5, 2018: These include a low CD4 count, having cirrhosis and taking certain hep C drug regimens.

Dec 17, 2018: However, while HbA1c and fasting glucose levels decline after a hep C cure, the clinical significance of such shifts remains unclear.

Apr 9, 2018: A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.

Dec 6, 2013: The FDA has approved Sovaldi (sofosbuvir), a once-daily oral nucleotide analog polymerase inhibitor to treat people with hepatitis C.

Apr 27, 2015: Daclatasvir and sofosbuvir cured 97 percent of hepatitis C among those with genotypes 1 through 4 of the virus who are coinfected with HIV.

Apr 2, 2018: In a recent small study of HIV-positive men who had recently contracted hepatitis C, Harvoni had a perfect cure rate.

May 14, 2018: People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.

Dec 11, 2017: In a recent small study of HIV-positive men who had recently contracted hepatitis C, Harvoni had a perfect cure rate.

Apr 29, 2013: Sofosbuvir and daclatasvir, taken with or without ribavirin, cured 100 percent of previously treated participants of hepatitis C virus in...

Nov 4, 2013: Sofosbuvir and ribavirin cured between 67 and 88 percent of those coinfected with HIV and genotypes 1, 2 or 3 of hepatitis C virus in a recent...